A 12-week, open label, multicentre study assessing the efficcay and of Donepezil in patients discontinuing treatment with Memantine monotherapy
Latest Information Update: 06 Aug 2021
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 06 Aug 2021 New trial record